L’ÉTUDE CLINIQUE DU MOIS TECOS : confirmation de la sécurité cardiovasculaire de la sitagliptine

Article French OPEN
SCHEEN, André; PAQUOT, Nicolas;
  • Subject: Cardiovascular risk | Congestive heart failure | Sitagliptin | DPP-4 inhibitor | Type 2 diabetes | : Pharmacy, pharmacology & toxicology [Human health sciences] | : Pharmacie, pharmacologie & toxicologie [Sciences de la santé humaine] | : Endocrinology, metabolism & nutrition [Human health sciences] | : Endocrinologie, métabolisme & nutrition [Sciences de la santé humaine]

Summary : The cardiovascular safety of sitagliptin has been evaluated in TECOS («Trial Evaluating Cardiovascular Outcomes with Sitagliptin»). TECOS recruited patients with type 2 diabetes and a history of cardiovascular disease who received, as add-on to their usual the... View more
Share - Bookmark